155 related articles for article (PubMed ID: 7997334)
1. Vascular targeting in photodynamic occlusion of subretinal vessels.
Schmidt-Erfurth U; Hasan T; Gragoudas E; Michaud N; Flotte TJ; Birngruber R
Ophthalmology; 1994 Dec; 101(12):1953-61. PubMed ID: 7997334
[TBL] [Abstract][Full Text] [Related]
2. [Selective occlusion of subretinal neovascularization with photodynamic therapy].
Schmidt-Erfurth U; Hasan T; Gragoudas E; Birngruber R
Ophthalmologe; 1994 Dec; 91(6):789-95. PubMed ID: 7849433
[TBL] [Abstract][Full Text] [Related]
3. Choriocapillaris photodynamic therapy using indocyanine green.
Costa RA; Farah ME; Freymüller E; Morales PH; Smith R; Cardillo JA
Am J Ophthalmol; 2001 Oct; 132(4):557-65. PubMed ID: 11589879
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).
Peyman GA; Moshfeghi DM; Moshfeghi A; Khoobehi B; Doiron DR; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1997 May; 28(5):409-17. PubMed ID: 9150524
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin.
Schmidt-Erfurth U; Bauman W; Gragoudas E; Flotte TJ; Michaud NA; Birngruber R; Hasan T
Ophthalmology; 1994 Jan; 101(1):89-99. PubMed ID: 8302569
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
[TBL] [Abstract][Full Text] [Related]
7. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
8. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative.
Lin SC; Lin CP; Feld JR; Duker JS; Puliafito CA
Curr Eye Res; 1994 Jul; 13(7):513-22. PubMed ID: 7523029
[TBL] [Abstract][Full Text] [Related]
9. [Expression of angiogenic factors by photodynamic therapy].
Rudolf M; Michels S; Schlötzer-Schrehardt U; Schmidt-Erfurth U
Klin Monbl Augenheilkd; 2004 Dec; 221(12):1026-32. PubMed ID: 15599809
[TBL] [Abstract][Full Text] [Related]
10. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors.
Schmidt-Erfurth U; Flotte TJ; Gragoudas ES; Schomacker K; Birngruber R; Hasan T
Exp Eye Res; 1996 Jan; 62(1):1-10. PubMed ID: 8674504
[TBL] [Abstract][Full Text] [Related]
11. [Photodynamic therapy of experimental, intraocular tumors with benzoporphyrin-lipoprotein].
Schmidt-Erfurth U; Hasan T; Flotte T; Gragoudas E; Birngruber R
Ophthalmologe; 1994 Jun; 91(3):348-56. PubMed ID: 8086752
[TBL] [Abstract][Full Text] [Related]
12. [Selective occlusion of ocular neovascularization by photodynamic therapy].
Schmidt U; Birngruber R; Hasan T
Ophthalmologe; 1992 Oct; 89(5):391-4. PubMed ID: 1304219
[TBL] [Abstract][Full Text] [Related]
13. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.
Haimovici R; Kramer M; Miller JW; Hasan T; Flotte TJ; Schomacker KT; Gragoudas ES
Curr Eye Res; 1997 Feb; 16(2):83-90. PubMed ID: 9068937
[TBL] [Abstract][Full Text] [Related]
14. Subretinal choroidal neovascularization as a response to penetrating retinal injury in the pigmented rabbit.
Hsu HT; Goodnight R; Ryan SJ
Jpn J Ophthalmol; 1989; 33(3):358-66. PubMed ID: 2796014
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES
Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
Potter MJ; Szabo SM; Chan EY; Morris AH
Am J Ophthalmol; 2002 Jan; 133(1):149-51. PubMed ID: 11755857
[TBL] [Abstract][Full Text] [Related]
17. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.
Moshfeghi DM; Peyman GA; Moshfeghi AA; Khoobehi B; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1998 Aug; 29(8):663-8. PubMed ID: 9715492
[TBL] [Abstract][Full Text] [Related]
18. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization.
Schmidt-Erfurth U; Hasan T; Schomacker K; Flotte T; Birngruber R
Lasers Surg Med; 1995; 17(2):178-88. PubMed ID: 8569414
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.
Smithen LM; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):884-5. PubMed ID: 15531339
[TBL] [Abstract][Full Text] [Related]
20. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
